Literature DB >> 27330682

Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study.

Maria Marsico1, Tommaso Gabbani1, Lorenzo Livi1, Maria Rosa Biagini1, Andrea Galli1.   

Abstract

AIM: To assess how the application of different types of markers affects the tracking accuracy of CyberKnife's.
METHODS: Fifteen patients were recruited and subjected to the ultrasound-guided placement of markers. Two different type of needles 25 gauge (G) and 17 G containing two different fiducial marker, gold notched flexible anchor wire 0.28 mm × 10 mm (25 G needle) and gold cylindrical grain 1 mm × 4 mm (17 G), were used. Seven days after the procedure, a CyberKnife planning computed tomography (CT) for the simulation of radiation treatment was performed on all patients. A binary CT score was assigned to the fiducial markers visualization. Also, the CT number was calculated for each fiducial and the values compared with a specific threshold.
RESULTS: For each patient from 1 to 5, intra-hepatic markers were placed (one in 2 patients, three in 8 patients, four in 3 patients, and five in 2 patients). A total of 48 needles were used (thirty-two 17 G and sixteen 25 G) and 48 gold markers were placed (32 Grain shaped markers and 16 Gold Anchor). The result showed that the CT visualization of the grain markers was better than the anchor markers (P = 5 × 10(-9)). Furthermore, the grain markers were shown to present minor late complications (P = 3 × 10(-6)), and the best CT threshold number (P = 0.0005).
CONCLUSION: The study revealed that the Gold Anchor fiducial marker is correlated with a greater number of late minor complications and low visualization by the CT.

Entities:  

Keywords:  CyberKnife; Fiducial markers; Liver malignancies; Radiation therapy; Robotic radiosurgery; Stereotactic radiosurgery

Year:  2016        PMID: 27330682      PMCID: PMC4911507          DOI: 10.4254/wjh.v8.i17.731

Source DB:  PubMed          Journal:  World J Hepatol


  32 in total

1.  The use of active breathing control (ABC) to reduce margin for breathing motion.

Authors:  J W Wong; M B Sharpe; D A Jaffray; V R Kini; J M Robertson; J S Stromberg; A A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

2.  Respiration gated radiotherapy treatment: a technical study.

Authors:  H D Kubo; B C Hill
Journal:  Phys Med Biol       Date:  1996-01       Impact factor: 3.609

Review 3.  [Stereotactic body radiotherapy].

Authors:  Tomoyuki Okabe; Tomoki Kimura; Yasushi Nagata
Journal:  Gan To Kagaku Ryoho       Date:  2014-12

4.  Safety profile and technical success of imaging-guided percutaneous fiducial seed placement with and without core biopsy in the abdomen and pelvis.

Authors:  Olga R Brook; Sofia Gourtsoyianni; Mishal Mendiratta-Lala; Anand Mahadevan; Bettina Siewert; Robert R Sheiman
Journal:  AJR Am J Roentgenol       Date:  2012-02       Impact factor: 3.959

Review 5.  Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Martin Kocher; Andrea Wittig; Marc Dieter Piroth; Harald Treuer; Heinrich Seegenschmiedt; Maximilian Ruge; Anca-Ligia Grosu; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

6.  EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies.

Authors:  Aline Charabaty Pishvaian; Brian Collins; Gregory Gagnon; Sushil Ahlawat; Nadim G Haddad
Journal:  Gastrointest Endosc       Date:  2006-09       Impact factor: 9.427

7.  Noninvasive patient fixation for extracranial stereotactic radiotherapy.

Authors:  F Lohr; J Debus; C Frank; K Herfarth; O Pastyr; B Rhein; M L Bahner; W Schlegel; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

8.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Regina V Tse; Maria Hawkins; Gina Lockwood; John J Kim; Bernard Cummings; Jennifer Knox; Morris Sherman; Laura A Dawson
Journal:  J Clin Oncol       Date:  2008-01-02       Impact factor: 44.544

9.  Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years.

Authors:  Alan J Katz; Michael Santoro; Fred Diblasio; Richard Ashley
Journal:  Radiat Oncol       Date:  2013-05-13       Impact factor: 3.481

10.  Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience.

Authors:  Kengo Ohta; Masashi Shimohira; Taro Murai; Junichi Nishimura; Hiromitsu Iwata; Hiroyuki Ogino; Takuya Hashizume; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2016-01-28       Impact factor: 2.724

View more
  2 in total

1.  Comparison of CT artifacts and image recognition of various fiducial markers including two types of thinner fiducial markers for CyberKnife treatment.

Authors:  Toshihiro Suzuki; Masahide Saito; Hiroshi Onishi; Koji Mochizuki; Kenichiro Satani; Akihiro Yamazaki; Kenichi Miura; Shinji Taka; Naoki Sano; Takafumi Komiyama; Hiroshi Takahashi
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-09

2.  Efficacy and safety of stereotactic radiosurgery for pulmonary metastases from osteosarcoma: Experience in 73 patients.

Authors:  Wenxi Yu; Zimei Liu; Lina Tang; Feng Lin; Yang Yao; Zan Shen
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.